Global Radioligand Therapy Market Growth (Status and Outlook) 2025-2031

April 2025 | 94 pages | ID: GB9B43AFE759EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Radioligand Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Radioligand Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Radioligand Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Radioligand Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Radioligand Therapy players cover Novartis, Advanced Accelerator Applications, Mercy Radiology, POINT Biopharma Global Inc, Fusion Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Radioligand Therapy Industry Forecast” looks at past sales and reviews total world Radioligand Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Radioligand Therapy sales for 2025 through 2031. With Radioligand Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radioligand Therapy industry.

This Insight Report provides a comprehensive analysis of the global Radioligand Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Radioligand Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radioligand Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radioligand Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radioligand Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Radioligand Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Actinium 225 (Ac-225)
• Lutetium 177 (Lu-177)
• Gallium 68 (Ga-68)
• Fluorine 18 (F-18)
• Other Radionuclides

Segmentation by Application:

• Neuroendocrine Neoplasms
• Prostate Cancer

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novartis
• Advanced Accelerator Applications
• Mercy Radiology
• POINT Biopharma Global Inc
• Fusion Pharma
• Telix Pharmaceuticals Ltd
• Lantheus Holdings, Inc
• Bayer AG
• Curium Pharma
• Precirix

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Radioligand Therapy Market Size (2020-2031)
  2.1.2 Radioligand Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Radioligand Therapy by Country/Region (2020, 2024 & 2031)
2.2 Radioligand Therapy Segment by Type
  2.2.1 Actinium 225 (Ac-225)
  2.2.2 Lutetium 177 (Lu-177)
  2.2.3 Gallium 68 (Ga-68)
  2.2.4 Fluorine 18 (F-18)
  2.2.5 Other Radionuclides
2.3 Radioligand Therapy Market Size by Type
  2.3.1 Radioligand Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Radioligand Therapy Market Size Market Share by Type (2020-2025)
2.4 Radioligand Therapy Segment by Application
  2.4.1 Neuroendocrine Neoplasms
  2.4.2 Prostate Cancer
2.5 Radioligand Therapy Market Size by Application
  2.5.1 Radioligand Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Radioligand Therapy Market Size Market Share by Application (2020-2025)

3 RADIOLIGAND THERAPY MARKET SIZE BY PLAYER

3.1 Radioligand Therapy Market Size Market Share by Player
  3.1.1 Global Radioligand Therapy Revenue by Player (2020-2025)
  3.1.2 Global Radioligand Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Radioligand Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RADIOLIGAND THERAPY BY REGION

4.1 Radioligand Therapy Market Size by Region (2020-2025)
4.2 Global Radioligand Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Radioligand Therapy Market Size Growth (2020-2025)
4.4 APAC Radioligand Therapy Market Size Growth (2020-2025)
4.5 Europe Radioligand Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Radioligand Therapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Radioligand Therapy Market Size by Country (2020-2025)
5.2 Americas Radioligand Therapy Market Size by Type (2020-2025)
5.3 Americas Radioligand Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Radioligand Therapy Market Size by Region (2020-2025)
6.2 APAC Radioligand Therapy Market Size by Type (2020-2025)
6.3 APAC Radioligand Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Radioligand Therapy Market Size by Country (2020-2025)
7.2 Europe Radioligand Therapy Market Size by Type (2020-2025)
7.3 Europe Radioligand Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Radioligand Therapy by Region (2020-2025)
8.2 Middle East & Africa Radioligand Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Radioligand Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RADIOLIGAND THERAPY MARKET FORECAST

10.1 Global Radioligand Therapy Forecast by Region (2026-2031)
  10.1.1 Global Radioligand Therapy Forecast by Region (2026-2031)
  10.1.2 Americas Radioligand Therapy Forecast
  10.1.3 APAC Radioligand Therapy Forecast
  10.1.4 Europe Radioligand Therapy Forecast
  10.1.5 Middle East & Africa Radioligand Therapy Forecast
10.2 Americas Radioligand Therapy Forecast by Country (2026-2031)
  10.2.1 United States Market Radioligand Therapy Forecast
  10.2.2 Canada Market Radioligand Therapy Forecast
  10.2.3 Mexico Market Radioligand Therapy Forecast
  10.2.4 Brazil Market Radioligand Therapy Forecast
10.3 APAC Radioligand Therapy Forecast by Region (2026-2031)
  10.3.1 China Radioligand Therapy Market Forecast
  10.3.2 Japan Market Radioligand Therapy Forecast
  10.3.3 Korea Market Radioligand Therapy Forecast
  10.3.4 Southeast Asia Market Radioligand Therapy Forecast
  10.3.5 India Market Radioligand Therapy Forecast
  10.3.6 Australia Market Radioligand Therapy Forecast
10.4 Europe Radioligand Therapy Forecast by Country (2026-2031)
  10.4.1 Germany Market Radioligand Therapy Forecast
  10.4.2 France Market Radioligand Therapy Forecast
  10.4.3 UK Market Radioligand Therapy Forecast
  10.4.4 Italy Market Radioligand Therapy Forecast
  10.4.5 Russia Market Radioligand Therapy Forecast
10.5 Middle East & Africa Radioligand Therapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market Radioligand Therapy Forecast
  10.5.2 South Africa Market Radioligand Therapy Forecast
  10.5.3 Israel Market Radioligand Therapy Forecast
  10.5.4 Turkey Market Radioligand Therapy Forecast
10.6 Global Radioligand Therapy Forecast by Type (2026-2031)
10.7 Global Radioligand Therapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Radioligand Therapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 Novartis
  11.1.1 Novartis Company Information
  11.1.2 Novartis Radioligand Therapy Product Offered
  11.1.3 Novartis Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Novartis Main Business Overview
  11.1.5 Novartis Latest Developments
11.2 Advanced Accelerator Applications
  11.2.1 Advanced Accelerator Applications Company Information
  11.2.2 Advanced Accelerator Applications Radioligand Therapy Product Offered
  11.2.3 Advanced Accelerator Applications Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Advanced Accelerator Applications Main Business Overview
  11.2.5 Advanced Accelerator Applications Latest Developments
11.3 Mercy Radiology
  11.3.1 Mercy Radiology Company Information
  11.3.2 Mercy Radiology Radioligand Therapy Product Offered
  11.3.3 Mercy Radiology Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Mercy Radiology Main Business Overview
  11.3.5 Mercy Radiology Latest Developments
11.4 POINT Biopharma Global Inc
  11.4.1 POINT Biopharma Global Inc Company Information
  11.4.2 POINT Biopharma Global Inc Radioligand Therapy Product Offered
  11.4.3 POINT Biopharma Global Inc Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 POINT Biopharma Global Inc Main Business Overview
  11.4.5 POINT Biopharma Global Inc Latest Developments
11.5 Fusion Pharma
  11.5.1 Fusion Pharma Company Information
  11.5.2 Fusion Pharma Radioligand Therapy Product Offered
  11.5.3 Fusion Pharma Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Fusion Pharma Main Business Overview
  11.5.5 Fusion Pharma Latest Developments
11.6 Telix Pharmaceuticals Ltd
  11.6.1 Telix Pharmaceuticals Ltd Company Information
  11.6.2 Telix Pharmaceuticals Ltd Radioligand Therapy Product Offered
  11.6.3 Telix Pharmaceuticals Ltd Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Telix Pharmaceuticals Ltd Main Business Overview
  11.6.5 Telix Pharmaceuticals Ltd Latest Developments
11.7 Lantheus Holdings, Inc
  11.7.1 Lantheus Holdings, Inc Company Information
  11.7.2 Lantheus Holdings, Inc Radioligand Therapy Product Offered
  11.7.3 Lantheus Holdings, Inc Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Lantheus Holdings, Inc Main Business Overview
  11.7.5 Lantheus Holdings, Inc Latest Developments
11.8 Bayer AG
  11.8.1 Bayer AG Company Information
  11.8.2 Bayer AG Radioligand Therapy Product Offered
  11.8.3 Bayer AG Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Bayer AG Main Business Overview
  11.8.5 Bayer AG Latest Developments
11.9 Curium Pharma
  11.9.1 Curium Pharma Company Information
  11.9.2 Curium Pharma Radioligand Therapy Product Offered
  11.9.3 Curium Pharma Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Curium Pharma Main Business Overview
  11.9.5 Curium Pharma Latest Developments
11.10 Precirix
  11.10.1 Precirix Company Information
  11.10.2 Precirix Radioligand Therapy Product Offered
  11.10.3 Precirix Radioligand Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Precirix Main Business Overview
  11.10.5 Precirix Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Radioligand Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Radioligand Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Actinium 225 (Ac-225)
Table 4. Major Players of Lutetium 177 (Lu-177)
Table 5. Major Players of Gallium 68 (Ga-68)
Table 6. Major Players of Fluorine 18 (F-18)
Table 7. Major Players of Other Radionuclides
Table 8. Radioligand Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Radioligand Therapy Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Radioligand Therapy Market Size Market Share by Type (2020-2025)
Table 11. Radioligand Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Radioligand Therapy Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Radioligand Therapy Market Size Market Share by Application (2020-2025)
Table 14. Global Radioligand Therapy Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Radioligand Therapy Revenue Market Share by Player (2020-2025)
Table 16. Radioligand Therapy Key Players Head office and Products Offered
Table 17. Radioligand Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Radioligand Therapy Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Radioligand Therapy Market Size Market Share by Region (2020-2025)
Table 22. Global Radioligand Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Radioligand Therapy Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Radioligand Therapy Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Radioligand Therapy Market Size Market Share by Country (2020-2025)
Table 26. Americas Radioligand Therapy Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Radioligand Therapy Market Size Market Share by Type (2020-2025)
Table 28. Americas Radioligand Therapy Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Radioligand Therapy Market Size Market Share by Application (2020-2025)
Table 30. APAC Radioligand Therapy Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Radioligand Therapy Market Size Market Share by Region (2020-2025)
Table 32. APAC Radioligand Therapy Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Radioligand Therapy Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Radioligand Therapy Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Radioligand Therapy Market Size Market Share by Country (2020-2025)
Table 36. Europe Radioligand Therapy Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Radioligand Therapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Radioligand Therapy Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Radioligand Therapy Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Radioligand Therapy Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Radioligand Therapy
Table 42. Key Market Challenges & Risks of Radioligand Therapy
Table 43. Key Industry Trends of Radioligand Therapy
Table 44. Global Radioligand Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Radioligand Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Radioligand Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Radioligand Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Novartis Details, Company Type, Radioligand Therapy Area Served and Its Competitors
Table 49. Novartis Radioligand Therapy Product Offered
Table 50. Novartis Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Novartis Main Business
Table 52. Novartis Latest Developments
Table 53. Advanced Accelerator Applications Details, Company Type, Radioligand Therapy Area Served and Its Competitors
Table 54. Advanced Accelerator Applications Radioligand Therapy Product Offered
Table 55. Advanced Accelerator Applications Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Advanced Accelerator Applications Main Business
Table 57. Advanced Accelerator Applications Latest Developments
Table 58. Mercy Radiology Details, Company Type, Radioligand Therapy Area Served and Its Competitors
Table 59. Mercy Radiology Radioligand Therapy Product Offered
Table 60. Mercy Radiology Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Mercy Radiology Main Business
Table 62. Mercy Radiology Latest Developments
Table 63. POINT Biopharma Global Inc Details, Company Type, Radioligand Therapy Area Served and Its Competitors
Table 64. POINT Biopharma Global Inc Radioligand Therapy Product Offered
Table 65. POINT Biopharma Global Inc Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. POINT Biopharma Global Inc Main Business
Table 67. POINT Biopharma Global Inc Latest Developments
Table 68. Fusion Pharma Details, Company Type, Radioligand Therapy Area Served and Its Competitors
Table 69. Fusion Pharma Radioligand Therapy Product Offered
Table 70. Fusion Pharma Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Fusion Pharma Main Business
Table 72. Fusion Pharma Latest Developments
Table 73. Telix Pharmaceuticals Ltd Details, Company Type, Radioligand Therapy Area Served and Its Competitors
Table 74. Telix Pharmaceuticals Ltd Radioligand Therapy Product Offered
Table 75. Telix Pharmaceuticals Ltd Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Telix Pharmaceuticals Ltd Main Business
Table 77. Telix Pharmaceuticals Ltd Latest Developments
Table 78. Lantheus Holdings, Inc Details, Company Type, Radioligand Therapy Area Served and Its Competitors
Table 79. Lantheus Holdings, Inc Radioligand Therapy Product Offered
Table 80. Lantheus Holdings, Inc Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Lantheus Holdings, Inc Main Business
Table 82. Lantheus Holdings, Inc Latest Developments
Table 83. Bayer AG Details, Company Type, Radioligand Therapy Area Served and Its Competitors
Table 84. Bayer AG Radioligand Therapy Product Offered
Table 85. Bayer AG Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Bayer AG Main Business
Table 87. Bayer AG Latest Developments
Table 88. Curium Pharma Details, Company Type, Radioligand Therapy Area Served and Its Competitors
Table 89. Curium Pharma Radioligand Therapy Product Offered
Table 90. Curium Pharma Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Curium Pharma Main Business
Table 92. Curium Pharma Latest Developments
Table 93. Precirix Details, Company Type, Radioligand Therapy Area Served and Its Competitors
Table 94. Precirix Radioligand Therapy Product Offered
Table 95. Precirix Radioligand Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Precirix Main Business
Table 97. Precirix Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Radioligand Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radioligand Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Radioligand Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Radioligand Therapy Sales Market Share by Country/Region (2024)
Figure 8. Radioligand Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Radioligand Therapy Market Size Market Share by Type in 2024
Figure 10. Radioligand Therapy in Neuroendocrine Neoplasms
Figure 11. Global Radioligand Therapy Market: Neuroendocrine Neoplasms (2020-2025) & ($ millions)
Figure 12. Radioligand Therapy in Prostate Cancer
Figure 13. Global Radioligand Therapy Market: Prostate Cancer (2020-2025) & ($ millions)
Figure 14. Global Radioligand Therapy Market Size Market Share by Application in 2024
Figure 15. Global Radioligand Therapy Revenue Market Share by Player in 2024
Figure 16. Global Radioligand Therapy Market Size Market Share by Region (2020-2025)
Figure 17. Americas Radioligand Therapy Market Size 2020-2025 ($ millions)
Figure 18. APAC Radioligand Therapy Market Size 2020-2025 ($ millions)
Figure 19. Europe Radioligand Therapy Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Radioligand Therapy Market Size 2020-2025 ($ millions)
Figure 21. Americas Radioligand Therapy Value Market Share by Country in 2024
Figure 22. United States Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Radioligand Therapy Market Size Market Share by Region in 2024
Figure 27. APAC Radioligand Therapy Market Size Market Share by Type (2020-2025)
Figure 28. APAC Radioligand Therapy Market Size Market Share by Application (2020-2025)
Figure 29. China Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 33. India Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Radioligand Therapy Market Size Market Share by Country in 2024
Figure 36. Europe Radioligand Therapy Market Size Market Share by Type (2020-2025)
Figure 37. Europe Radioligand Therapy Market Size Market Share by Application (2020-2025)
Figure 38. Germany Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. France Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Radioligand Therapy Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Radioligand Therapy Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Radioligand Therapy Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Radioligand Therapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 52. APAC Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 53. Europe Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 55. United States Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 56. Canada Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 57. Mexico Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 58. Brazil Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 59. China Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 60. Japan Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 61. Korea Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 63. India Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 64. Australia Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 65. Germany Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 66. France Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 67. UK Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 68. Italy Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 69. Russia Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 70. Egypt Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 71. South Africa Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 72. Israel Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 73. Turkey Radioligand Therapy Market Size 2026-2031 ($ millions)
Figure 74. Global Radioligand Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Radioligand Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Radioligand Therapy Market Size 2026-2031 ($ millions)